ask="5.15"
ask_size="8800"
average_daily_volume="411705"
bid="4.02"
bid_size="500"
book_value="3.74"
change="+0.12"
change_from_200_day_moving_average="1.87"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-6.66"
change_From_52_week_low="0.83"
change_in_percent="+2.86%"
close="4.32"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13913000"
high="4.34"
high_52_weeks="10.98"
last_trade_date="2/8/2017"
last_trade_price="4.32"
last_trade_size="8932"
last_trade_time="4:00pm"
low="4.02"
low_52_weeks="3.49"
market_capitalization="97.42M"
moving_average_200_day="2.45"
moving_average_50_day="4.37"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.16"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+76.58%"
percent_change_from_50_day_moving_average="-1.24%"
percent_change_from_52_week_high="-60.66%"
percent_change_from_52_week_low="+23.78%"
previous_close="4.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.12"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="6.55"
stock_exchange="NMS"
symbol="CASC"
volume="207564"
weeks_range_52="3.49 - 10.98"
